共 50 条
- [41] Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists [J]. Molecular Psychiatry, 2022, 27 : 3562 - 3562
- [42] Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19 [J]. INFECTION AND CHEMOTHERAPY, 2022, 54 (02): : 370 - 371
- [43] Fluvoxamine for outpatients with COVID-19: where do we stand? [J]. LANCET GLOBAL HEALTH, 2022, 10 (01): : E2 - E3
- [47] RETROSPECTIVE REVIEW OF MELATONIN IN PATIENTS WITH COVID-19 [J]. CHEST, 2021, 160 (04) : 560A - 560A
- [49] Therapeutic Benefits of Melatonin Against COVID-19 [J]. NEUROIMMUNOMODULATION, 2023, 30 (01) : 196 - 205